Adverse effects of montelukast examined by FDA's Pediatric Advisory Committee
October 1st 2014At its late September meeting, the Pediatric Advisory Committee (PAC) to the US Food and Drug Administration (FDA) said it’s time to remind healthcare professionals that Singulair (montelukast) may have adverse effects on mental and behavioral functions.
Parental supervision enhances adolescents' prelicense driving skills
October 1st 2014A web-based program that guides parents in supervising their children’s practice drives with focus on specific skills in a variety of driving environments improves driving performance in prelicensed 16- and 17-year-olds, a trial of such a program showed.
Antiviral compound shows promise as therapy for RSV
October 1st 2014The oral respiratory syncytial virus (RSV) entry inhibitor GS-5806 reduces both viral load and clinical manifestations of RSV infection, according to results of a trial in which investigators infected healthy adults with a nasally delivered clinical strain of RSV.
Sickle cell anemia raises risk for obstructive sleep apnea syndrome
October 1st 2014Children with sickle cell anemia (SCA) are more likely to have obstructive sleep apnea syndrome (OSAS) than the general pediatric population, with habitual snoring and low waking pulse oxygen saturation the strongest risk factors for developing the condition.
Pulse oximetry: The fifth vital sign
October 1st 2014It is easy to take for granted some of the technologies we use every day. The pulse oximeter was invented 40 years ago and has become such a routine part of medical practice that oximetry measurements have often been referred to as the “fifth vital sign.”
FDA's sunscreen recommendations
October 1st 2014The need to protect the skin from excessive sun exposure from ultraviolet radiation (UVR) is now well established based on studies showing a clear causal link between excessive UVR exposure and damage to the skin that raises the risk of skin cancer and leads to premature aging.
Cystic fibrosis: An essential update
October 1st 2014The prognosis for patients with cystic fibrosis (CF) continues to improve because of a combination of advances in the understanding of disease pathophysiology, implementation of early screening and diagnosis, and greater emphasis on proactive management to prevent deterioration and disease progression.
Isotretinoin risks in acne treatment
October 1st 2014When it comes to isotretinoin, dermatology experts say, pediatricians should advise parents not to believe everything they read online. Furthermore, patients can't always be relied upon to comply with the birth-control requirements for using the drug.
New screening guide for congenital heart disease
September 25th 2014The American Heart Association and the American College of Cardiology have jointly issued a new scientific statement on screening for congenital and genetic heart conditions that can lead to rare sudden death in young persons aged 12 to 25 years.
New clinical guidelines for treatment of SCD
September 18th 2014An expert panel of specialists from the National Heart, Lung, and Blood Institute has issued new guidelines for the management and treatment of sickle cell disease (SCD). How will these latest evidence-based recommendations affect the care of your patients?